ARCHIVES

Alimta Reduces Risk Of Progression In Patients Aged 70 Years or Older

This article is from The Cancer Letter archive.

Vol. 34 No. 10 | October 28, 2011

Download PDF Visit The Full Archive

Related Articles

In Brief: Rogers On AHF Board; GAO Says Legislation May Needed For Hospice Reimbursement

March 23, 1979

Harkin, Hatfield Propose Trust Fund to Raise Research Funding

May 28, 1993

Avastin Phase III Trial Meets Endpoint: PFS in Platinum-Sensitive Ovarian Cancer

February 25, 2011

Conferees Stalled On Money Bill, Running Out Of Time

September 17, 1976

St. John’s Wort Not Indicated For Patients On Irinotecan

May 31, 2002

FDA Committee Okays Leuprolide NDA, But Recommends Against Mitoxantrne, Epirubicin

April 5, 1985